Holen Sie sich die Stockscreener-App
111.23
0.21%
-0.48
Handel nachbörslich:
111.00
-0.23
-0.21%
Schlusskurs vom Vortag:
$111.71
Offen:
$108.58
24-Stunden-Volumen:
689.49K
Relative Volume:
0.66
Marktkapitalisierung:
$3.79B
Einnahmen:
$531.29M
Nettoeinkommen (Verlust:
$71.66M
KGV:
57.52
EPS:
1.9338
Netto-Cashflow:
$17.35M
1W Leistung:
-3.22%
1M Leistung:
-2.70%
6M Leistung:
+28.36%
1J Leistung:
-16.96%
1-Tages-Spanne:
$108.34
$114.66
1-Wochen-Bereich:
$107.22
$119.29
52-Wochen-Spanne:
$55.00
$145.50
Transmedics Group Inc Stock (TMDX) Company Profile
Firmenname
Transmedics Group Inc
Sektor
Branche
Telefon
(978) 552-0900
Adresse
200 MINUTEMAN ROAD, ANDOVER, MA
Vergleichen Sie TMDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
111.23 | 3.81B | 531.29M | 71.66M | 17.35M | 1.9338 |
|
ABT
Abbott Laboratories
|
133.26 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.88 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.53 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.35 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-16 | Eingeleitet | Evercore ISI | Outperform |
| 2025-09-04 | Eingeleitet | Stifel | Hold |
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Herabstufung | Needham | Buy → Hold |
| 2024-10-29 | Bestätigt | Needham | Buy |
| 2024-10-29 | Bestätigt | Oppenheimer | Outperform |
| 2024-09-24 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-21 | Eingeleitet | Needham | Buy |
| 2024-06-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Eingeleitet | Stephens | Overweight |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-05-28 | Eingeleitet | Cowen | Outperform |
| 2019-05-28 | Eingeleitet | JP Morgan | Overweight |
| 2019-05-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten
TransMedics Group (NASDAQ:TMDX) Earns "Buy" Rating from Canaccord Genuity Group - MarketBeat
How to use Fibonacci retracement on TransMedics Group Inc.2025 Trading Volume Trends & Community Trade Idea Sharing - newser.com
Total Clarity Wealth Management Inc. Invests $386,000 in TransMedics Group, Inc. $TMDX - MarketBeat
Will TransMedics Group Inc. stock outperform value stocksEarnings Growth Summary & Verified Short-Term Plans - newser.com
Is TransMedics Group Inc Gaining or Losing Market Support? - Sahm
Signal strength of TransMedics Group Inc. stock in tech scannersGlobal Markets & Daily Chart Pattern Signal Reports - newser.com
Jefferies Initiates TransMedics Group at Buy With $145 Price Target - MarketScreener
Jefferies Initiates Coverage on TransMedics Group (TMDX) with a 'Buy' Rating | TMDX Stock News - GuruFocus
Backtesting results for TransMedics Group Inc. trading strategies2025 Pullback Review & Reliable Price Breakout Alerts - newser.com
Can swing trading help recover from TransMedics Group Inc. lossesLong Setup & Technical Pattern Alert System - newser.com
TransMedics Group Inc. stock prediction for this weekWeekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
TransMedics Group (NASDAQ:TMDX) Earns Buy Rating from Analysts at Jefferies Financial Group - MarketBeat
Jefferies Initiates Coverage of TransMedics Group (TMDX) with Buy Recommendation - Nasdaq
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out - ACCESS Newswire
Blair William & Co. IL Trims Stock Holdings in TransMedics Group, Inc. $TMDX - MarketBeat
SLT Holdings LLC Makes New Investment in TransMedics Group, Inc. $TMDX - MarketBeat
Is it time to cut losses on TransMedics Group Inc.Earnings Miss & AI Forecast Swing Trade Picks - newser.com
How to escape a deep drawdown in TransMedics Group Inc.Weekly Earnings Recap & Real-Time Market Sentiment Alerts - newser.com
TransMedics Group, Inc. $TMDX Shares Acquired by Valmark Advisers Inc. - MarketBeat
Detecting price anomalies in TransMedics Group Inc. with AIWeekly Stock Summary & Long-Term Growth Stock Strategies - newser.com
Weiss Ratings Reaffirms Hold (C) Rating for TransMedics Group (NASDAQ:TMDX) - MarketBeat
There's Been No Shortage Of Growth Recently For TransMedics Group's (NASDAQ:TMDX) Returns On Capital - Yahoo Finance
Regression analysis insights on TransMedics Group Inc. performanceEarnings Overview Summary & Short-Term Swing Trade Alerts - newser.com
2 Outstanding Healthcare Stocks to Buy and Hold for a Decade - AOL.com
TransMedics Group (NASDAQ:TMDX) Rating Lowered to Hold at Zacks Research - MarketBeat
TransMedics Stock (NASDAQ: TMDX) Q3 Financial Results - AskTraders.com
TransMedics (TMDX) Faces Potential Revenue Shortfall in Q3 - GuruFocus
Global Assets Advisory LLC Sells 12,550 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group Acquires Aircraft for Organ Transport - TipRanks
Tools to assess TransMedics Group Inc.’s risk profileJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com
Leading vs lagging indicators on TransMedics Group Inc. performance2025 AllTime Highs & Safe Entry Point Alerts - newser.com
Is TransMedics Group Inc. forming a reversal patternTrade Entry Report & Weekly Chart Analysis and Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Price momentum metrics for TransMedics Group Inc. explainedM&A Rumor & Weekly High Conviction Ideas - newser.com
TransMedics Group's (NASDAQ:TMDX) Investors Will Be Pleased With Their Enviable 736% Return Over the Last Five Years - 富途牛牛
Published on: 2025-10-03 05:43:58 - newser.com
Is TransMedics Group Inc. stock bottoming outJuly 2025 Chart Watch & Advanced Swing Trade Entry Alerts - newser.com
GC Wealth Management RIA LLC Makes New Investment in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group (NASDAQ:TMDX) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat
Published on: 2025-10-01 05:23:50 - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect - ACCESS Newswire
Reversal indicators forming on TransMedics Group Inc. stockQuarterly Trade Summary & AI Powered Market Entry Ideas - newser.com
Park Avenue Securities LLC Invests $445,000 in TransMedics Group, Inc. $TMDX - MarketBeat
Published on: 2025-09-29 09:16:08 - newser.com
Taylor Frigon Capital Management LLC Trims Stock Position in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group, Inc. (TMDX) Stock Analysis: A 23% Upside Potential in the Innovative Organ Transplant Sector - DirectorsTalk Interviews
TransMedics Group, Inc. (TMDX) Stock Analysis: Unpacking a 23.53% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Finanzdaten der Transmedics Group Inc-Aktie (TMDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Transmedics Group Inc-Aktie (TMDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hassanein Waleed H | President & CEO |
Aug 07 '25 |
Buy |
116.25 |
8,475 |
985,209 |
486,234 |
| Basile Edward M | Director |
Aug 04 '25 |
Option Exercise |
0.70 |
4,143 |
2,900 |
7,009 |
| Basile Edward M | Director |
Aug 04 '25 |
Sale |
125.51 |
4,143 |
519,988 |
2,866 |
1.22%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):